European doctors call for a pharmaceutical strategy that provides citizens with medicines they need at a price they are able to pay. Over time, the trust in the pharmaceutical sector and its ability to promote the development of medical innovations while ensuring sustainable access has been eroded. The confidence in how that system works must […]

European doctors contributed to the forthcoming European Commission’s Pharmaceutical Strategy by providing their comments on the recently published roadmap. We emphasise the importance of regaining the trust in the pharma sector and rebuilding the confidence in the patient-centred system that serves public interests. CPME agrees with the roadmap that the strategy must be patient-centred. It […]

A number of European organisations representing not-for-profit healthcare insurers, healthcare professionals, public interest organisations and trade unions have developed and endorsed recommendations to bring fairer medicines prices in Europe. As the European Commission is consulting on its forthcoming European Pharmaceutical Strategy and that the current crisis strained severely health systems and public budgets, signatories of […]

European organisations react to a recent update in the pharmaceutical industry’s Code of Practice. A group of European organisations active in the field of transparency issued a joint statement to highlight the shortcomings in the new European Federation of Pharmaceutical Industries and Associations (EFPIA) Code of Practice. The response raises concerns about the privileges granted […]

CPME response to public consultation on how the EMA engages with medicine developers before they apply for authorisations to market their medicines in the EU 

On 11 June 2015, the CPME Executive Committee adopted the ’CPME response to the EMA Good practice guides on medication errors’ (CPME 2015/062 FINAL)

On 23 November 2013, the CPME Board endorsed the WMA Declaration of Helsinki on ethical principles for medical research involving human subjects, as adopted by the WMA General Assembly in Fortaleza – Brazil, October 2013.

On 17 September 2013, the CPME Executive Committee adopted the “ CPME Response to the EMA public consultation on the “Publication and access to clinical-trial data” Policy” (CPME 2013/088 FINAL)

On 13 June 2013, the CPME Executive Committee adopted the “CPME Response to the WMA public consultation on the draft revised text of the Declaration of Helsinki”